DOUBLED SALES AND A FOCUS ON INCREASING CAPACITY Financial development third quarter 2025 The third quarter order intake amounted to SEK 907 million (415), equivalent to an increase of 119%, of which ...

Ferring Pharmaceuticals announced today that three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 101st Annual Meeting of the Western Section of the American ...

Journal Times Staff Oct 24, 2025 Oct 24, 2025 0 ...